Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting

Scott J. Leischow, James Ranger-Moore, Myra L. Muramoto, Eva Matthews

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Objective: To evaluate the effectiveness of the Nicotrol® nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. Methods: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. Results: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was .77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low. Conclusions: OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.

Original languageEnglish (US)
Pages (from-to)291-301
Number of pages11
JournalAmerican Journal of Health Behavior
Issue number4
StatePublished - Jan 1 2004


  • Nicotine inhaler
  • OTC
  • Smoking cessation
  • nicotine replacement.

ASJC Scopus subject areas

  • Health(social science)
  • Social Psychology
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting'. Together they form a unique fingerprint.

Cite this